What is ORF Genetics?
ORF Genetics is an Icelandic biotechnology firm that has developed a proprietary barley-based expression system for producing high-purity, animal-free recombinant growth factors and cytokines. These advanced biological components are critical for applications spanning stem cell research, regenerative medicine, cultivated meat production, and the skincare industry. The company's innovative approach addresses a growing demand for reliable and ethically sourced biological materials in these rapidly evolving fields.
How much funding has ORF Genetics raised?
ORF Genetics has raised a total of $5.8M across 1 funding round:
Other Financing Round
$5.8M
Other Financing Round (2025): $5.8M, investors not publicly disclosed
What's next for ORF Genetics?
The recent major strategic investment signals a pivotal growth phase for ORF Genetics. This financing is expected to accelerate the company's research and development initiatives, scale its production capabilities, and expand its market reach. With a focus on enterprise-level funding, ORF Genetics is poised to further solidify its leadership in providing essential biomaterials for cutting-edge life science and consumer product applications.
See full ORF Genetics company page
